Communiqués Labcorp Holdings Inc.

Actions

LH

US5049221055

Installations et services en soins de santé

Marché Fermé - NYSE 22:00:02 11/09/2026			Pré-ouverture 15:29:02
311,54 ^USD	+1,49%		314,36	+0,90%

11/09	Labcorp Holdings Inc. : UBS maintient sa recommandation à l'achat	ZM
10/09	Transcript : Labcorp Holdings Inc. - Analyst/Investor Day

Communiqués

10/09	WRITER Unveils Enterprise Brain, the First Universal Context Layer to Power the Agentic Customer Journey	AQ
10/09	Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day	PR
10/09	Everlywell Leads 2026 Ranking of At-Home Lab Test Companies	AQ
08/09	Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials	PR
31/08	Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference	AQ
31/08	Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity	PR
28/08	Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference	PR
24/08	Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings	PR
24/08	FTC Reaches $2.1M Settlement Over Search Advertising	AQ
18/08	Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health	PR
17/08	Labcorp to Host Investor Day on September 10, 2026	PR
10/08	Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma	PR
04/08	Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer	PR
30/07	Labcorp: Q2 Earnings Snapshot	AQ
30/07	Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance	PR
27/07	Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing	PR
09/07	Labcorp Declares Quarterly Dividend	PR
30/06	Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026	PR
23/06	Labcorp Announces Nationwide Availability of ColoSense(R), the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test	AQ
22/06	Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test	PR
29/05	Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer	PR
28/05	Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects	PR
27/05	Labcorp to Present at the Jefferies Global Healthcare Conference	PR
20/05	Labcorp Launches MyLabcorp™, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time	PR
12/05	Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems	PR